Professor Raphael Mechoulam, also known as the “father of cannabis research,” revealed his latest discovery, cannabidiolic acid methyl ester (EPM301), only a few months ago. The introduction of this new, patented compound (synthetic, fully stable acid-based cannabinoid molecules) caused a wave of excitement around the future of medicinal cannabis.
Those who have tried cannabis said it was far more effective than any of the FDA-approved drugs. Sixty-two percent who have tried cannabis said it was very effective at treating their fibromyalgia symptoms. Another 33% said it helped a little & only 5% said it did not help at all.
Professor Pertwee received the accolade from the International Cannabinoid Research Society (ICRS) for his highly cited research into pharmacological actions of constituents of cannabis known as phytocannabinoids, and of cannabinoids designed and synthesized by medicinal chemists.